Search Ontology:
ChEBI

LLY-507

Term ID
CHEBI:228258
Synonyms
  • 5-cyano-2'-{4-[2-(3-methyl-1H-indol-1-yl)ethyl]piperazin-1-yl}-N-[3-(pyrrolidin-1-yl)propyl][biphenyl]-3-carboxamide
  • LLY 507
  • LLY507
Definition
A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-cyano-2'-{4-[2-(3-methyl-1H-indol-1-yl)ethyl]piperazin-1-yl}[biphenyl]-3-carboxylic acid with the amino group of 3-(pyrrolidin-1-yl)propan-1-amine. It is a potent and selective inhibitor of SMYD2 and inhibits the ability of SMYD2 to methylate p53. It serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes.
References
  • cas:1793053-37-8
  • pubmed:25825497
  • pubmed:30955858
  • pubmed:31730617
  • pubmed:33011288
  • pubmed:33407870
  • pubmed:34510321
  • pubmed:36270984
  • pubmed:37513898
  • pubmed:37524453
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from LLY-507
Phenotype where environments contain LLY-507
Phenotype modified by environments containing LLY-507
Phenotype affecting LLY-507
Human Disease Model